TY - JOUR
T1 - Boosting antimicrobial activity of ciprofloxacin by functionalization of mesoporous silica nanoparticles
AU - Mora, Blanca de Juan
AU - Filipe, Luís
AU - Forte, Andreia
AU - Santos, Miguel M.
AU - Alves, Celso
AU - Teodoro, Fernando
AU - Pedrosa, Rui
AU - Carrott, Manuela Ribeiro
AU - Branco, Luís C.
AU - Gago, Sandra
N1 - info:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDB%2F50006%2F2020/PT#
info:eu-repo/grantAgreement/FCT/3599-PPCDT/PTDC%2FQUI-QOR%2F32406%2F2017/PT#
UID/MAR/04292/2020
PEst-C/LA0006/2013
RECI/BBBBQB/0230/2012
MAR-02.01.01-FEAMP-0042–INOVA4AQUA
022161
PY - 2021/2/5
Y1 - 2021/2/5
N2 - Mesoporous silica nanoparticles (MSNs) are very promising nanomaterials for treating bacterial infections when combined with pharmaceutical drugs. Herein, we report the preparation of two nanomaterials based on the immobilization of ciprofloxacin in mesoporous silica nanoparticles, either as the counter-ion of the choline derivative cation (MSN-[Ch][Cip]) or via anchoring on the surface of amino-group modified MSNs via an amide bond (MSN-Cip). Both nanomaterials were characterized by TEM, FTIR and solution1H NMR spectroscopies, elemental analysis, XRD and N2 adsorption at 77 K in order to provide the desired structures. No cytotoxicity from the prepared mesoporous nanoparticles on 3T3 murine fibroblasts was observed. The antimicrobial activity of the nanomaterials was determined against Gram-positive (Staphylococcus aureus and Bacillus subtilis) and Gram-negative (Klebsiella pneumoniae) bacteria and the results were promising against S. aureus. In the case of B. subtilis, both nanomaterials exhibited higher antimicrobial activity than the precursor [Ch][Cip], and in the case of K. pneumoniae they exhibited higher activity than neutral ciprofloxacin.
AB - Mesoporous silica nanoparticles (MSNs) are very promising nanomaterials for treating bacterial infections when combined with pharmaceutical drugs. Herein, we report the preparation of two nanomaterials based on the immobilization of ciprofloxacin in mesoporous silica nanoparticles, either as the counter-ion of the choline derivative cation (MSN-[Ch][Cip]) or via anchoring on the surface of amino-group modified MSNs via an amide bond (MSN-Cip). Both nanomaterials were characterized by TEM, FTIR and solution1H NMR spectroscopies, elemental analysis, XRD and N2 adsorption at 77 K in order to provide the desired structures. No cytotoxicity from the prepared mesoporous nanoparticles on 3T3 murine fibroblasts was observed. The antimicrobial activity of the nanomaterials was determined against Gram-positive (Staphylococcus aureus and Bacillus subtilis) and Gram-negative (Klebsiella pneumoniae) bacteria and the results were promising against S. aureus. In the case of B. subtilis, both nanomaterials exhibited higher antimicrobial activity than the precursor [Ch][Cip], and in the case of K. pneumoniae they exhibited higher activity than neutral ciprofloxacin.
KW - Antimicrobial activity
KW - Ciprofloxacin
KW - Cytotoxicity
KW - Ionic liquids
KW - Mesoporous silica nanoparticles
UR - http://www.scopus.com/inward/record.url?scp=85100783010&partnerID=8YFLogxK
U2 - 10.3390/pharmaceutics13020218
DO - 10.3390/pharmaceutics13020218
M3 - Article
C2 - 33562597
AN - SCOPUS:85100783010
SN - 1999-4923
VL - 13
SP - 1
EP - 16
JO - Pharmaceutics
JF - Pharmaceutics
IS - 2
M1 - 218
ER -